Cabergoline
Showing 1 - 25 of 81
Lactation Suppressed Trial in Stanford (Cabergoline 1 MG, Placebo)
Not yet recruiting
- Lactation Suppressed
- Cabergoline 1 MG
- Placebo
-
Stanford, CaliforniaStanford University
Sep 1, 2023
Polycystic Ovary Syndrome Trial in Al Qadisiyah (Metformin Hydrochloride 500 MG, Cabergoline 0.5 MG, Metformin Hydrochloride 500
Completed
- Polycystic Ovary Syndrome
- Metformin Hydrochloride 500 MG
- +2 more
-
Al Qādisīyah, Al-Qādisiyyah Governorate, IraqMaternity and Pediatric Teaching Hospital
Jul 31, 2023
Lactation Suppressed Trial in Afula (Cabergoline, Pyridoxine)
Completed
- Lactation Suppressed
- Cabergoline
- Pyridoxine
-
Afula, IsraelHaEmek Medical Center
Nov 10, 2022
Lactation Suppressed Trial in Stanford (Cabergoline 1 MG, Placebo)
Active, not recruiting
- Lactation Suppressed
- Cabergoline 1 MG
- Placebo
-
Stanford, CaliforniaStanford University
Jul 7, 2022
Pituitary Tumors, Adenoma Trial in Oslo, Trondheim, Gøteborg (cabergoline)
Recruiting
- Pituitary Neoplasms
- Adenoma
- cabergoline
-
Oslo, Norway
- +2 more
Jan 19, 2023
Lactation Suppressed, Second Trimester Abortion Trial in Chicago (Cabergoline, Placebo)
Not yet recruiting
- Lactation Suppressed
- Second Trimester Abortion
- Cabergoline
- Placebo
-
Chicago, IllinoisNorthwestern Medical Center
Nov 7, 2023
Factors and Outcomes Associated With Postpartum Cabergoline Use
Recruiting
- Lactation Suppressed
- +3 more
-
Netanya, IsraelLaniado Hospital, The Betty Retter Mother & Baby Medical Center
Sep 27, 2021
Infertility, Female Trial in Las Vegas (Cabergoline Pill)
Completed
- Infertility, Female
- Cabergoline Pill
-
Las Vegas, NevadaFertility Center of Las vegas
Jun 11, 2021
Endometriosis Trial in Boston (Cabergoline 0.5 MG, Placebo - Cap)
Recruiting
- Endometriosis
- Cabergoline 0.5 MG
- Placebo - Cap
-
Boston, Massachusetts
- +1 more
Mar 16, 2021
Pituitary Adenoma, Prolactinoma, Pituitary Tumor Trial in Seoul (Cabergoline)
Recruiting
- Pituitary Adenoma
- +3 more
- Cabergoline
-
Seoul, Korea, Republic ofSeoul National University Hospital
Mar 17, 2020
Cushings Disease Trial in Worldwide (Pasireotide with or without cabergoline)
Terminated
- Cushings Disease
- Pasireotide with or without cabergoline
-
Birmingham, Alabama
- +28 more
Aug 28, 2020
Recurrent Breast Cancer, Stage IV Breast Cancer Trial in Chicago (cabergoline)
Completed
- Recurrent Breast Cancer
- Stage IV Breast Cancer
- cabergoline
-
Chicago, IllinoisNorthwestern University
Sep 4, 2019
Endometriosis Trial in Boston (Cabergoline, Norethindrone acetate)
Completed
- Endometriosis
- Cabergoline
- Norethindrone acetate
-
Boston, MassachusettsChildren's Hospital Boston
Jan 27, 2020
Cushing's Disease, Acromegaly, Neuroendocrine Tumors Trial in Worldwide (Pasireotide, Cabergoline)
Active, not recruiting
- Cushing's Disease
- +8 more
- Pasireotide
- Cabergoline
-
La Jolla, California
- +93 more
May 19, 2022
OHSS Trial in Giza (Cabergoline, Calcium gluconate)
Completed
- OHSS
- Cabergoline
- Calcium gluconate
-
Giza, Egypt
- +1 more
Dec 25, 2018
Lactation Suppressed Trial in Warsaw (Bromocriptine, Cabergoline, Natural methods)
Unknown status
- Lactation Suppressed
- Bromocriptine
- +2 more
-
Warsaw, PolandŻelazna Medical Centre
Jul 26, 2019
Estetrol/Drospirenone to Reduce Average Size of Endometriomas
Not yet recruiting
- Ovarian Endometrioma
- Endometrioma
-
Montreal, Quebec, CanadaMcGill University Health Center
Apr 27, 2023
Ovarian Hyperstimulation Syndrome Trial in Singapore (Cabergoline, Placebo)
Completed
- Ovarian Hyperstimulation Syndrome
- Cabergoline
- Placebo
-
Singapore, SingaporeKK Women's and Children's Hospital
Aug 5, 2018
Parkinson Disease Trial in France (Surgery under general anesthesia with experimental targeting, Usual Surgery)
Recruiting
- Parkinson Disease
- Surgery under general anesthesia with experimental targeting
- Usual Surgery
-
Amiens, France
- +9 more
May 31, 2022
Resistance, Disease, Prolactinoma Trial in China (HCQ/CQ and CAB combined treatment)
Unknown status
- Resistance, Disease
- Prolactinoma
- HCQ/CQ and CAB combined treatment
-
Beijing, Beijing, China
- +8 more
Oct 14, 2018
Infertility Trial (Clomiphene Citrate 50mg, Cabergoline Oral Tablet, Placebo Oral Tablet)
Unknown status
- Infertility
- Clomiphene Citrate 50mg
- +2 more
- (no location specified)
May 26, 2018
Cushing Disease Trial in France (Patient group, Remission control group, Bilateral surrenalectomy control group)
Recruiting
- Cushing Disease
- Patient group
- +2 more
-
Caen, France
- +6 more
Dec 16, 2021
Ovarian Hyperstimulation Syndrome Trial in Cairo (Late Cabergoline 0.5mg, Early Cabergoline 0.5mg)
Unknown status
- Ovarian Hyperstimulation Syndrome
- Late Cabergoline 0.5mg
- Early Cabergoline 0.5mg
-
Cairo, EgyptIVF department in Kasr Alaini hospital,private IVF centre
Apr 8, 2018
Ovarian Hyperstimulation Trial in Cairo (Oral Cabergoline, Calcium Gluconate)
Completed
- Ovarian Hyperstimulation
- Oral Cabergoline
- Calcium Gluconate
-
Cairo, Elqalopia, EgyptAshraf nassif Elmantwe
Mar 27, 2018